Federica Biello
0000-0002-1360-989X
37 papers found
Refreshing results…
Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancer
The Role of the Immune Metabolic Prognostic Index in Patients with Non-Small Cell Lung Cancer (NSCLC) in Radiological Progression during Treatment with Nivolumab
Insulin/IGF Axis in Breast Cancer: Clinical Evidence and Translational Insights
Baseline serum levels of osteopontin predict clinical response to treatment with nivolumab in patients with non-small cell lung cancer
Serum PCSK9 levels at the second nivolumab cycle predict overall survival in elderly patients with NSCLC: a pilot study
Nivolumab treatment in advanced lung cancer patient with chronic active hepatitis C and systemic lupus erythematosus
Integrated Somatic and Germline Whole-Exome Sequencing Analysis in Women with Lung Cancer after a Previous Breast Cancer
The role of CEA, CYFRA21-1 and NSE in monitoring tumor response to Nivolumab in advanced non-small cell lung cancer (NSCLC) patients
What is the best pharmacotherapeutic strategy for HER-2 positive breast cancer?
Afatinib and Erlotinib in the treatment of squamous-cell lung cancer
The evolving role of pemetrexed disodium for the treatment of non-small cell lung cancer
CIMAvax-EGF, a therapeutic non-small cell lung cancer vaccine
Serial Troponin for Early Detection of Nivolumab Cardiotoxicity in Advanced Non‐Small Cell Lung Cancer Patients
Prognostic role of the VeriStrat test in first line patients with non-small cell lung cancer treated with platinum-based chemotherapy
Downregulation of miR-99a/let-7c/miR-125b miRNA cluster predicts clinical outcome in patients with unresected malignant pleural mesothelioma
Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy
Circulating Tumor DNA Reflects Tumor Metabolism Rather Than Tumor Burden in Chemotherapy-Naive Patients with Advanced Non–Small Cell Lung Cancer: 18F-FDG PET/CT Study
Releasing the brake: safety profile of immune check-point inhibitors in non-small cell lung cancer
Investigational drugs targeting fibroblast growth factor receptor in the treatment of non-small cell lung cancer
Whole exome sequencing of independent lung adenocarcinoma, lung squamous cell carcinoma, and malignant peritoneal mesothelioma
Missing publications? Search for publications with a matching author name.